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Intracrine Androgens Enhance 
Decidualization and Modulate 
Expression of Human Endometrial 
Receptivity Genes
Douglas A. Gibson1, Ioannis Simitsidellis1, Fiona L. Cousins1,†, Hilary O. D. Critchley2 & 
Philippa T. K. Saunders1
The endometrium is a complex, steroid-dependent tissue that undergoes dynamic cyclical remodelling. 
Transformation of stromal fibroblasts (ESC) into specialised secretory cells (decidualization) is 
fundamental to the establishment of a receptive endometrial microenvironment which can support 
and maintain pregnancy. Androgen receptors (AR) are present in ESC; in other tissues local metabolism 
of ovarian and adrenal-derived androgens regulate AR-dependent gene expression. We hypothesised 
that altered expression/activity of androgen biosynthetic enzymes would regulate tissue availability of 
bioactive androgens and the process of decidualization. Primary human ESC were treated in vitro for 
1–8 days with progesterone and cAMP (decidualized) in the presence or absence of the AR antagonist 
flutamide. Time and treatment-dependent changes in genes essential for a) intra-tissue biosynthesis 
of androgens (5α-reductase/SRD5A1, aldo-keto reductase family 1 member C3/AKR1C3), b) 
establishment of endometrial decidualization (IGFBP1, prolactin) and c) endometrial receptivity (SPP1, 
MAOA, EDNRB) were measured. Decidualization of ESC resulted in significant time-dependent changes 
in expression of AKR1C3 and SRD5A1 and secretion of T/DHT. Addition of flutamide significantly 
reduced secretion of IGFBP1 and prolactin and altered the expression of endometrial receptivity 
markers. Intracrine biosynthesis of endometrial androgens during decidualization may play a key role in 
endometrial receptivity and offer a novel target for fertility treatment.
In fertile women the endometrium ‘prepares’ for implantation of a blastocyst by a period of post-ovulatory 
(progesterone-dependent) tissue remodelling. This process is controlled by endometrial stromal cells (ESC) that 
undergo decidualization, a process of differentiation, that results in transformation from proliferating fibroblasts 
to specialised secretory cells capable of producing factors that promote endometrial receptivity and regulate mul-
tiple cell types including those of the immune and vascular systems1. Recent studies from our laboratory have 
revealed that decidualization of ESC results in significant changes in biosynthesis and metabolism of estrogens 
(estrone and estradiol)2 which alters the function of uterine natural killer and endometrial endothelial cells3. 
These results have prompted us to propose a pivotal role for intra-uterine steroid biosynthesis in the establish-
ment of a receptive endometrium. Androgens are natural precursors to estrogens but can also regulate functional 
processes through binding and activating the androgen receptor (AR). In the current study we have investigated 
whether tissue specific synthesis of androgens can play a role in regulation of decidualization.
The human endometrium is an androgen target tissue and androgen receptors (AR) are expressed in the 
endometrium throughout the menstrual cycle. Our detailed analysis of full thickness sections of human endo-
metrium has revealed intense regional and stage-dependent immunoexpression in ESC4 highlighting them as a 
key target for androgen action. In women, androgens are secreted both by the ovary and the adrenal gland5 with 
production declining with age6. Circulating concentrations of androgens are high throughout the menstrual cycle 
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with a mid-cycle peak in concentrations of the AR agonist testosterone (T) at the time of ovulation7. Circulating 
concentrations of dihydrotestosterone (DHT) are low and do not change across the cycle7 but this is not unex-
pected as DHT is primarily a product of peripheral T metabolism within target tissues and thus there is a poor 
correlation between circulating and tissue-specific concentrations of DHT. The adrenal androgen dehydroepian-
drosterone (DHEA) and its sulphate (DHEAS) are abundant in the circulation and can act as a precursor to both 
estrogens and androgens (Supplementary Figure 1). DHEA is converted to androstenedione (A4) by the action 
of the enzyme 3-β -hydroxysteroid dehydrogenase (3β HSD) which we have previously reported is expressed in 
decidualized endometrium and in isolated ESC2. A4 is a weak AR agonist but can be converted to T by the 
aldo-keto reductase family 1 member C3 (AKR1C3; also known as 17β -HSD5). T can act as a precursor for estro-
gen biosynthesis by the action of aromatase (encoded by CYP19A1)2 or converted to the potent non-aromatisable 
androgen DHT via the action of 5α -reductase type 1 (encoded by SRD5A1). In the 1970s Rose et al. detected 
conversion to DHT in human endometrial homogenates co-incubated with radiolabelled testosterone8. Recent 
evidence using advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) has extended these 
initial observations by demonstrating that intra-tissue hormone concentrations in endometrial homogenates 
are distinct from circulating concentrations9,10 consistent with a potential role for local activation of androgens 
within the endometrium.
Primary stromal cells isolated from human endometrium (ESC) can be stimulated to undergo a robust 
decidualization response by the addition of progesterone and the second messenger molecule cyclic adenosine 
monophosphate (cAMP)11. This in vitro decidualization phenocopies the post-ovulatory differentiation of ESC 
during a fertile cycle with characteristic changes in cellular morphology11 and increased secretion of proteins such 
as insulin-like growth factor-binding protein 1 (IGFBP1)12 and prolactin13. Some in vitro studies have used the 
synthetic progestin medroxyprogesterone acetate (MPA) in place of progesterone. As MPA is reported to activate 
the AR, in addition to its well-known role as a progesterone receptor (PR) agonist14, changes in gene expression 
detected using this agent may represent a combination of PR- and AR-dependent effects. Additional evidence from 
studies comparing the behaviour of human ESC decidualized with progesterone plus cAMP combined with the 
addition of exogenous DHT have reported that regulation of prolactin secretion, morphological transformation 
of ESC and resistance to oxidative stress are augmented by androgen action15–17. Genomic studies using in silico 
and knockdown approaches have reported that DHT and AR-dependent signaling can regulate distinct gene net-
works in decidualized human ESC with evidence for a role in cell survival, cell cycle regulation and cytoskeletal 
organisation4,18. Studies conducted in rodents suggest androgens play an important role in the establishment and 
maintenance of pregnancy in those species. In rats administration of the AR antagonist flutamide is reported to 
suppress decidualization and delay initiation of implantation19. Female mice lacking a functional Ar have altered 
neuroendocrine signalling and ovarian function and are subfertile20; studies using ovarian transplantation suggest 
Ar plays a key role in uterine development21. Taken together, these data are consistent with the uterus being an 
androgen target tissue and that AR-dependent signalling is essential for the regulation of uterine function.
In androgen target tissues local activation of circulating precursors regulate AR-dependent gene expression 
but whether local metabolism and activation of androgens occurs within the endometrium is not known. In the 
current study we tested the hypothesis that changes in intra-uterine bioavailability of androgens would have a 
direct impact on endometrial tissue function. We demonstrate that decidualization of ESC is associated with local 
biosynthesis of androgens. Our novel data demonstrate that intracrine androgens can complement the effects of 
progesterone by acting to enhance the decidualization response and support an optimal environment for success-
ful establishment of pregnancy.
Results
Decidualization is associated with biosynthesis of testosterone. The expression of AKR1C3 was 
dynamically regulated across the decidualization time course. Concentrations of AKR1C3 mRNA were increased 
in ESC treated with decidualization media (DM) for 1, 2 and 4 days with a significant peak in expression detected 
after 2 and 4 days of treatment (Fig. 1A, n = 8 p < 0.0001). Western blot analysis revealed a significant increase 
in total AKR1C3 protein in decidualized ESC compared to control after 4 (Fig. 1B, n = 8 p < 0.05) and 8 days 
(Fig. 1C, n = 8 p < 0.05). Immunofluorescence revealed positive staining for AKR1C3 (red) immunolocalised 
in the cytoplasm of both control and decidualized ESC treated for 4 days (Fig. 1D) although staining was more 
intense in decidualized cells consistent with the pattern of expression detected by Western blot. A significant 
increase in concentrations of T was detected in media recovered after 4 and 8 days of decidualization compared 
with controls (Fig. 1E, n = 8 p < 0.01)). Metabolism of testosterone to A4 was assessed by TLC and was found to 
be significantly decreased in decidualized cells further augmenting net production of T (Supplementary Figure 
2; p < 0.05).
Decidualization is associated with time-dependent changes in expression of SRD5A1 and bio-
synthesis of dihydrotestosterone. The enzyme SRD5A1 catalyses the conversion of T to the potent 
endogenous androgen DHT. Interestingly, the expression of SRD5A1 mRNAs were significantly decreased after 
1 (Fig. 2A; n = 8 p < 0.01) and 2 days (Fig. 2A; n = 8 p < 0.05) but unchanged compared to control at 8 days. 
Western blot analysis revealed expression of SRD5A1 in cell lysates from both control and decidualized cells that 
was unchanged after 4 days of treatment (Fig. 2B) but significantly decreased in decidualized ESC compared to 
control after 8 days of treatment (Fig. 2C, n = 7 p < 0.0001). Immunofluorescence staining of ESC treated for 4 
days confirmed positive staining for SRD5A1 (red) immunolocalised in the cytoplasm of both control and decid-
ualized ESC (Fig. 2D). Although SRD5A1 protein was detected in both control and decidualized ESC, significant 
concentrations of DHT were only detected in supernatants from decidualized ESC (Fig. 2E, n = 8 p < 0.0001); 
concentrations of DHT were significantly decreased in day 8 compared to day 4 decidualized ESC (Fig. 2E, n = 8 
p < 0.001).
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Blocking intracrine androgen action with flutamide inhibits decidualization. As decidualization 
of ESC resulted in biosynthesis of T and DHT we investigated whether these androgens could act as intracrine 
regulators of decidualization. Markers of decidual transformation were compared in ESC incubated with control 
media, DM or DM plus the specific AR antagonist flutamide. Cell morphology was assessed in ESC and con-
trol cells had an elongated fibroblast-like morphology and decidualized (DEC) ESC exhibited classic rounded, 
‘epithelioid’ morphology (Fig. 3A). Consistent with inhibition of decidualization, flutamide treated cells (DEC 
Flut) exhibited limited morphological evidence of decidualization with mostly fibroblast-like morphology and 
few rounded cells (Fig. 3A). The presence of flutamide had a significant impact on expression of both IGFBP1 
and prolactin: Concentrations of mRNAs encoded by IGFBP1 were significantly reduced by flutamide treatment 
after 1 (Fig. 3B; n = 6 p < 0.001), 2 (p < 0.0001) and 4 days (p < 0.05). PRL mRNA was significantly decreased 
at 2 (Fig. 3C; n = 6 p < 0.0001) and 4 days (Fig. 3C; n = 6 p < 0.05). Mean concentrations of secreted IGFBP1 
protein detected in culture media from cells incubated with flutamide were significantly decreased after 4 days 
(Fig. 3D; n = 6 p < 0.01) and 8 days (Fig. 3D; n = 6 p < 0.0001) compared to DEC alone. Mean concentrations 
of secreted Prolactin protein detected in culture media from cells incubated with DM plus flutamide were sig-
nificantly decreased after 1, 2 and 4 days (Fig. 3E; n = 6 p < 0.05, p < 0.01, p < 0.0001) compared to DM alone. 
Notably, mean concentrations of secreted IGFBP1 and Prolactin were decreased approximately 80% by flutamide 
treatment after 4 days.
Addition of flutamide altered expression of putative androgen-regulated receptivity 
genes. Candidate receptivity genes were selected by comparing androgen-regulated genes4 with genes pre-
viously validated as playing an essential role in endometrial receptivity22,23. Incubation of ESC with DM resulted 
in significant time-dependent changes in concentrations of mRNAs and proteins encoded by SPP1, MAOA and 
EDNRB: changes induced by addition of flutamide were consistent with a role for androgens in regulation of these 
Figure 1. Decidualization is associated with time-dependent changes in expression of AKR1C3 and 
biosynthesis of testosterone. The expression of the androgen biosynthetic enzyme AKR1C3, which converts A4 
to T, was assessed by qPCR, Western blot and immunocytochemistry in ESC. AKR1C3 was increased following 
decidualization of ESC. (A) Concentrations of mRNAs encoding AKR1C3 were significantly increased in ESC 
treated to decidualized (DEC) for 2 and 4 days compared to control (Control, p < 0.0001, n = 8) but by day 8 
mRNA expression was unchanged between control and decidualized ESC. (B) Western blot analysis of AKR1C3 
expression from homogenates of ESC treated for 4 days revealed a significant increase in AKR1C3 protein in 
decidualized ESC (n = 4 patients per treatment, p < 0.05). (C) Western blot analysis of AKR1C3 expression 
from homogenates of ESC treated for 8 days revealed a significant increase in AKR1C3 protein in decidualized 
ESC (n = 6 patients per treatment, p < 0.05). Representative blots from 4 matched patients are shown (B,C). 
Loading control b-actin (red, 43 kDa), AKR1C3 (green, 37 kDa). (D) The expression of AKR1C3 was assessed 
by immunocytochemistry in ESC grown in chamber slides and treated to decidualize for 4 days. AKR1C3 
expression was detected in both control and decidualized ESC (AKR1C3; red staining). Staining appeared 
more intense in decidualized ESC (DEC). Nuclear counterstain SytoxGreen (SYTOX; green staining), scale 
bar 100 μ m. In the absence of primary antibody no staining was detected (inset). (E) Concentrations of T were 
assessed by ELISA and significant concentrations of T were detected in cell culture supernatants recovered from 
decidualized ESC at 4 (n = 8, p < 0.01) and 8 days (n = 8, p < 0.01). *p < 0.05, **p < 0.01, ****p < 0.0001.
www.nature.com/scientificreports/
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3 genes. Osteopontin/Secreted Phosphoprotein 1 (SPP1) is reported to be an essential mediator of implantation 
and receptivity in women24,25 and is reported to be increased in decidualized ESC26. SPP1 mRNA was significantly 
increased in ESC treated to decidualize (DEC) for 4 (Fig. 4A; n = 8 p < 0.05) and 8 days (Fig. 4A; n = 8 p < 0.001). 
Concentrations of SPP1 mRNA were lower in cells treated with flutamide and this was significant at the 8-day 
time point (Fig. 4A; n = 8 p < 0.05). SPP1 is a phosphoprotein which is secreted in active form from cells to 
mediate effects in tissues. Concentrations of SPP1 protein in cell culture supernatants was therefore assessed by 
ELISA. Interestingly, the concentrations of SPP1 detected in culture media varied widely between patients but 
were generally lower after 8 days flutamide treatment compared to DEC (Supplementary Figure 3) and undetect-
able in control supernatants. To account for inter-patient variability, protein concentrations were calculated as 
fold change relative to DEC which revealed SPP1 secretion was significantly decreased with flutamide treatment 
at 8 days (Fig. 4B, n = 8 p < 0.01).
Incubation with DM alone significantly increased monoamine oxidase (MAOA) mRNA concentrations after 
1 (Fig. 4C; n = 8 p < 0.001), 2 (Fig. 4C; n = 8 p < 0.001) and 4 days (Fig. 4C; n = 8 p < 0.05) but was not signifi-
cantly different from controls at 8 days. Interestingly, the impact of flutamide treatment on MAOA mRNA expres-
sion was also time-dependent; on days 1–4 addition of flutamide had no effect on MAOA mRNAs compared to 
DM alone but on day 8 concentrations were significantly increased in ESC treated with flutamide compared to 
control (Fig. 4D; n = 8, p < 0.05). Western blot analysis of MAOA revealed that addition of flutamide had a strik-
ing effect on total protein concentrations in cells on day 8 compared to both control (Fig. 4D, n = 8, p < 0.001) 
and DM alone (Fig. 4D, n = 8, p < 0.01).
Figure 2. Decidualization is associated with time-dependent changes in expression of SRD5A1 and 
biosynthesis of dihydrotestosterone. The expression of the androgen biosynthetic enzyme SRD5A1, which 
reduces T to the more potent androgen DHT, was assessed by qPCR, Western blot and immunocytochemistry 
in ESC. (A) Concentrations of mRNAs encoding SRD5A1 were significantly decreased in ESC treated with 
DM for 1 and 2 days compared to control (Control, p < 0.01 and p < 0.05 respectively, n = 8) but by day 
8 mRNA expression was unchanged between control and decidualized ESC. (B) Western blot analysis of 
5α -reductase (SRD5A1) expression from homogenates of ESC treated for 4 days revealed that 5α -reductase 
protein in was detected in control and decidualized ESC (n = 4 patients per treatment) (C) Western blot analysis 
of 5α -reductase expression from homogenates of ESC treated for 8 days revealed a significant decrease in 
5α -reductase protein in decidualized ESC (n = 7 patients per treatment, p < 0.0001), representative blots from 
4 matched patients are shown (B,C). Loading control b-actin (red, 43 kDa), 5α -reductase (green, 100 kDa). 
(D) The expression of 5α -reductase was assessed by immunocytochemistry in ESC grown in chamber slides 
and treated to decidualize for 4 days. 5α -reductase expression was detected in both control and decidualized 
ESC (SRD5A1; Red staining). Staining appeared to be similar in both control and decidualized ESC (DEC). 
Nuclear counterstain SytoxGreen (SYTOX; green staining), scale bar 100 μ m. In the absence of primary 
antibody no staining was detected (Inset). (E) Concentrations of DHT were assessed by ELISA and significant 
concentrations of DHT were detected in cell culture supernatants recovered from decidualized ESC at 4 (n = 8, 
p < 0.0001) and 8 days (n = 8, p < 0.0001). Concentrations of DHT were significantly decreased in day 8 
compared to day 4 decidualized ESC (p < 0.001). *p < 0.05, **p < 0.01, ****p < 0.0001.
www.nature.com/scientificreports/
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Endothelin receptor B (EDNRB) binds members of the endothelin family of proteins that are reported to reg-
ulate endometrial blood flow27. The expression of EDNRB was also dynamically regulated during decidualization 
Figure 3. Blocking local androgen action inhibits decidualization. To investigate if androgens produced 
by ESC could affect decidualization, ESC were co-treated with the anti-androgen flutamide and markers 
of decidual transformation were assessed. (A) Cell morphology was assessed in ESC by phase-contrast 
microscopy. Control ESC had an elongated fibroblast-like morphology and decidualized (DEC) ESC had a 
rounded, ‘epithelioid’ morphology. Flutamide treated cells (DEC Flut) were mostly fibroblast-like with few 
rounded cells. (B) Concentrations of mRNAs encoding IGFBP1 were significantly reduced after 1 (n = 6, 
p < 0.001), 2 (n = 6, p < 0.0001) and 4 days (n = 6, p < 0.05) of flutamide treatment but were unchanged after 8 
days. (C) Concentrations of mRNAs encoding PRL were significantly decreased after 2 (n = 6, p < 0.0001) and 4 
days (n = 6, p < 0.05) of flutamide treatment and tended to be lower in flutamide treated ESC after 8 days.  
(D) Secretion of the decidualization marker IGFBP1 was assessed by ELISA. Secretion of IGFBP1 was 
significantly reduced by flutamide treatment (DEC Flut). A striking 80% reduction in secretion of IGFBP1 was 
detected at 4 days (n = 6, p < 0.01) and 30% reduction was detected after 8 days of flutamide treatment (n = 6, 
p < 0.0001) compared to DEC. (E) Secretion of Prolactin was significantly reduced by flutamide treatment after 
1 (n = 6, p < 0.05) and 2 days (n = 6, p < 0.01). A striking 81% reduction in secretion of Prolactin was detected 
at 4 days (n = 6, p < 0.0001) and secretion of Prolactin tended to be lower in flutamide treated ESC after 8 days 
compared to DEC ESC (n = 6). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
www.nature.com/scientificreports/
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Figure 4. The impact of flutamide on expression of putative androgen-regulated receptivity genes. To 
investigate if androgens produced by ESC could affect expression of putative androgen-regulated endometrial 
receptivity genes, ESC were co-treated with the anti-androgen flutamide and the expression of osteopontin 
(SPP1), monoamine oxidase (MAOA) and endothelin receptor B (EDNRB) were assessed. (A) Concentrations 
of mRNAs encoding SPP1 were significantly increased in decidualized ESC after 4 (p < 0.05) and 8 days 
treatment (p < 0.001) and significantly reduced in ESC co-treated with flutamide (n = 8, p < 0.05) at 8 days. (B) 
Concentrations of secreted SPP1 were detected by ELISA and calculated as fold change relative to decidualized 
ESC. SPP1 was not detected in supernatants from control cultures (ND). Co-treatment with flutamide 
significantly reduced secretion of SPP1 (n = 8, p < 0.01) and reduced the relative secretion of SPP1 by ~40%. 
(C) Concentrations of mRNAs encoding MAOA were significantly increased in decidualized ESC after 1 
(p < 0.001), 2 (p < 0.001) and 4 days treatment (p < 0.05). MAOA mRNA expression was significantly increased 
relative to control in ESC co-treated with flutamide for 8 days (n = 8, p < 0.05). (D) Western blot analysis of 
MAOA expression from homogenates of ESC treated for 8 days revealed that MAOA protein was detected in 
control and decidualized ESC (n = 8 patients per treatment), and significantly increased in ESC co-treated with 
flutamide relative to control and decidualized ESC (n = 8, p < 0.001 and p < 0.01). Representative blots from 4 
matched patients are shown. Loading control b-actin (red, 43 kDa), MAOA (green, 60 kDa). (E) Concentrations 
of mRNAs encoding EDNRB tended to be increased at each time point and were significantly increased in 
decidualized ESC after 8 days treatment (n = 8, p < 0.001). EDNRB mRNA expression was reduced in ESC co-
treated with flutamide (F) Western blot analysis of EDNRB expression from homogenates of ESC treated for 8 
days revealed that EDNRB protein was detected in control and decidualized ESC (n = 8 patients per treatment), 
and significantly increased in ESC treated to decidualize (p < 0.05). Co-treatment with flutamide significantly 
reduced concentrations EDNRB detected relative to decidualized ESC (n = 8, p < 0.001). Representative blots 
from 4 matched patients are shown. Loading control b-actin (red, 43 kDa), EDNRB (green, 50 kDa). *p < 0.05, 
**p < 0.01, ***p < 0.001, ****p < 0.0001.
www.nature.com/scientificreports/
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of ESC. Decidualization led to a significant increase in the concentrations of EDNRB mRNAs in ESC treated to 
decidualize for 4 (Fig. 4E, n = 8 p < 0.05) and 8 days (Fig. 4E, n = 8 p < 0.001). Incubation with flutamide resulted 
in an apparent (non-significant) decrease in EDNRB mRNA compared to DM alone although concentrations 
were increased relative to control at 4 (Fig. 4E, n = 8 p < 0.01) and 8 days (Fig. 4E, n = 8 p < 0.001). On Western 
blots EDNRB protein was readily detected in all treatment groups, was significantly increased after 8 days treat-
ment with DM (Fig. 4F, n = 8 p < 0.05) but this increase was completely abrogated by inclusion of flutamide 
(Fig. 4F, n = 8 p < 0.001; DEC vs DEC Flut). Flutamide treatment also decreased EDNRB protein expression after 
4 days of treatment compared to DM alone (Supplementary Figure 4A, n = 4 p < 0.05) however MAOA was not 
detected by Western blot at this time point (Supplementary Figure 4B).
Discussion
Endometrial receptivity is a time-sensitive process underpinned by dynamic changes in the transformation of the 
stromal compartment and coordinated stromal-epithelial cross-talk. To our knowledge we present the first data 
that demonstrate endometrial stromal cells promote formation of a pro-androgenic microenvironment during 
decidualization. Critically, we found that changes in androgen metabolism and biosynthesis are time-dependent, 
suggesting androgens will be most abundant within areas of the tissue at early stages of decidualization. We found 
that incubation with the selective AR antagonist flutamide had a significant effect on gene expression within 
primary human ESC over the time course of decidualization. Notably in this study we did not add exogenous T 
or DHT therefore the impact of flutamide on gene transcription and protein biosynthesis provides evidence of 
intracrine androgen activity. We noted that blocking intracrine androgens both inhibited and delayed expression 
of proteins implicated as markers of the decidualization response and endometrial receptivity (Summarised in 
Fig. 5).
The human endometrium has been extensively investigated using transcriptional profiling22,23. A customised 
array based on 238 genes (The Endometrial Receptivity Array (ERA)22) has been validated and is in current use 
in the clinic to optimise management and timing of embryo transfer for women undergoing assisted reproduc-
tion, including those with repeated implantation failure. In studies using primary ESC our group has previously 
identified and validated a set of androgen responsive genes that were expressed in the human endometrium 
during the normal cycle4. In the present study we identified putative androgen-regulated receptivity genes by 
cross-referencing the ERA gene list22 with our ‘androgen target gene’ set4. Three putative androgen-regulated 
genes were identified; MAOA, EDNRB and SPP1. Blocking local androgen action resulted in time-dependent 
inhibition of SPP1 and EDNRB expression and altered expression of MAOA in decidualized ESC. Decidualization 
of ESC precedes implantation in the human endometrium and thus the expression of receptivity factors such as 
SPP1, MAOA and EDNRB may be affected by inadequate decidualization and alterations in androgen signalling. 
Expression of MAOA is reported to be enhanced in the endometrium during the window of implantation and 
deficient expression is associated with implantation failure28. SPP1 is the only factor identified that is common to 
all reported endometrial receptivity gene sets22,23 and is reported to be an essential mediator of implantation and 
receptivity in humans24,25. The novel findings in the present study demonstrate that biosynthesis of androgens 
Figure 5. Summary: The impact of intracrine androgens on endometrial function. Decidualization of 
stromal cells is a time-dependent process that is associated with changes in synthesis of bioactive steroids. 
During the first 4 days of decidualization increased expression and activity of AKR1C3 promotes biosynthesis 
of T which is converted to the potent androgen DHT by the action of SRD5A1. T and DHT produced by ESC 
signal via an intracrine mechanism to regulate the early decidualization response leading to characteristic 
transformation of cellular morphology and secretion of decidualization markers. Blocking intracrine androgens 
with the AR antagonist flutamide inhibits decidualization, limiting the morphological transformation of 
ESC and inhibiting the production of decidualization (IGFBP1 and prolactin) and receptivity factors (SPP1, 
EDNRB). Inadequate T/DHT biosynthesis may result in a transcriptional profile that is ‘out of phase’ which may 
impact on the establishment and maintenance of pregnancy in women.
www.nature.com/scientificreports/
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within endometrial tissue during the early secretory phase may play an essential role in maintaining SPP1 and 
EDNRB expression in ESC which could have important implications for the regulation of implantation. Timing of 
implantation and endometrial receptivity has a major impact on the establishment of a successful pregnancy and 
on the future health of offspring. It has been reported that the majority of conceptions can be detected between 
days 22 and 24 of the menstrual cycle29 and that delayed implantation is associated with increased rates of early 
pregnancy loss30,31. The data in the current study suggest that a deficit in local bioavailable androgens may delay 
endometrial maturation and might be a previously unrecognised factor contributing to a transcriptional profile 
that is ‘out of phase’.
Insufficient androgen signalling may be detrimental to the regulation of decidualization however exposure 
to excess androgens may also adversely affect endometrial function. Elevated AR expression has been reported 
in endometrium of women with polycystic ovarian syndrome (PCOS)32,33 a complex metabolic disorder asso-
ciated with ovarian dysfunction, irregular menstrual cycles and in some cases hyperandrogenism. In a recent 
study, Piltonen et al. reported that in ESC isolated from women with PCOS (fulfilling all Rotterdam criteria; 
oligo-amenorrhea, PCO and hyperandrogenism) response to decidualization induced by estradiol (E2) and pro-
gesterone was significantly reduced, however this was only in a small subset of the patients that were analysed32. 
These results suggest that altered androgen signalling may have a detrimental effect on endometrial function in 
women, however further studies are needed to elucidate the importance of these effects in complex disorders such 
as PCOS. Notably, complementary studies in rodents demonstrate that insufficient or excess concentrations of 
androgens can delay implantation or lead to aberrant gene expression in implantation sites respectively33.
The widely reported age-related decline in fertility is often considered as an exclusively ovarian phenomenon 
but there is emerging evidence that reduced androgen bioavailability may result in endometrial ‘senescence’ a 
phenomenon that has received little attention to date. Concentrations of circulating androgens decline precipi-
tously with age34, such that concentrations of adrenal androgens at age 40 are half those at age 216. Changes in the 
availability of precursor androgens in circulation may impact on intracrine signalling in the endometrium and 
thus the regulation of implantation. We have previously reported that ESC express 3β HSD the enzyme responsi-
ble for converting adrenal androgens within target tissues2 and we speculate that a reduction in the availability of 
circulating androgen precursors could limit the development of a full and robust decidualization response which 
may contribute to reduced fertility in older women. Studies evaluating the effect of DHEA supplementation on 
reproductive outcomes have produced conflicting results and have been limited by a lack of randomised con-
trolled trials (RCT). A recent meta-analysis pooling data from 8 studies (including two RCTs) investigated the 
impact of DHEA supplementation on clinical pregnancy rate and number of oocytes retrieved in women with 
diminished ovarian reserve undergoing in vitro fertilisation or intracytoplasmic sperm injection35. The study 
reported that DHEA supplementation significantly increased clinical pregnancy rate but there was no significant 
effect on oocyte retrieval, implantation or abortion35. These findings are in agreement with the conclusions of the 
recent Cochrane review on androgen/DHEA supplementation for women undergoing assisted reproduction that 
reported that DHEA or testosterone supplementation may be associated with improved live birth rates but further 
evidence from well-designed studies is required before definitive conclusions can be made36.
In the current study we provide further novel insights into the regulation of decidualization by profiling dis-
crete responses of ESC across a time-course up to 8 days whereas many other studies only consider the response 
of cells after 6 or more days incubation15,26. We demonstrate rapid and sustained induction of AKR1C3 resulting 
in a significant increase in secretion of T which was maintained throughout the culture period. Notably, con-
centrations of DHT in media were significantly higher on day 4 than day 8 which may in part reflect reduced 
expression of SRD5A1. An alternative explanation for the reduced concentrations of DHT would be a switch 
towards conversion of T to E2 a hypothesis that would be consistent with our recent study in which we reported 
that E2 biosynthesis increases in a time-dependent manner during decidualization due to an increase in expres-
sion of aromatase (CYP19A1) by 8 days decidualization2. Furthermore, we have demonstrated that local E2 plays 
an important role in the endometrium by regulating immune and vascular function in early pregnancy3. These 
complementary data suggest perturbations in formation of androgens and the androgen-estrogen balance could 
have a major impact on the endometrial microenvironment as a result of intracrine androgen regulation of stro-
mal decidualization and paracrine estrogen regulation of immune-vascular function. Taken together these data 
indicate that T may play a dual role in the endometrium as both a precursor to DHT in early decidualization and 
as a precursor to estrogens as decidualization progresses and pregnancy is established.
The results of this study suggest a new paradigm for understanding control of endometrial remodelling in 
which local androgens modulate decidualization and promote coordinated development of the endometrial 
microenvironment. Critically, we describe a novel role for androgens that is both distinct from and complemen-
tary to the long-established role of progesterone in promoting post-ovulatory tissue remodelling in women. We 
demonstrate that androgens regulate early remodelling events by affecting endometrial transcription and altering 
the expression of decidualization and receptivity markers. These data suggest intra-uterine androgens may be 
critical for decidualization and thus impact on establishment and maintenance of pregnancy.
Materials and Methods
Patients, endometrial tissue resource and cell cultures. Human endometrial tissue (proliferative 
phase, n = 20) was obtained from women undergoing surgery for non-malignant gynaecological conditions. 
None of the women were receiving hormonal therapy or suffering from endometriosis. Cycle phase was deter-
mined as previously reported37. Written informed consent was obtained from all subjects prior to surgery, and 
ethical approval was granted by the Lothian Research Ethics Committee (LREC 10/S1402/59). Methods were car-
ried out in accordance with NHS Lothian Tissue Governance guidelines. Primary endometrial stromal cells (ESC) 
were isolated from proliferative phase endometrium as described previously37. Decidualization was induced by 
addition of decidualization media (DM: RPMI 1640, 2% charcoal-stripped FCS, 0.1 mg/ml 8-Br-cAMP (Sigma 
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B5386), 1 μ M progesterone (Tocris, Cat no. 2835). Some cells were incubated with the antiandrogen flutamide for 
the duration of the culture period (10 μ M; Sigma F9397). Control cultures were incubated with RPMI 1640, 2% 
charcoal-stripped FCS and equivalent volume of vehicle control (DMSO). To assess the time-dependent accumu-
lation of secreted products treatments were maintained for the duration of each time point. ESC were treated for 
1, 2, 4 and 8 days as indicated.
Measurement of mRNA and protein. Isolation of mRNAs, preparation of cDNAs, and analysis by qRT-
PCR was performed according to standard protocols (11); samples were quantified by standard curve method or by 
the comparative Δ Δ Ct method with CYC as internal control. Primers/probes are given in Supplemental Table 1.
Western blotting was performed using 50 μ g/lane total cell lysates; membranes were probed with rabbit or 
goat anti-SRD5A1 (Santa-Cruz Biotech; sc-20658 and sc-20396); rabbit anti-AKR1C3 (Abcam, Ab137546); rab-
bit anti-Monoamine Oxidase A (Abcam, ab126751) or rabbit anti-Endothelin B Receptor (Abcam ab129102). 
SRD5A1 was not detected at the predicted molecular weight (29 kDa) but consistently detected at around 100 kDa 
at all reducing conditions tested (50–250 mM dithiothreitol; DTT, β -mercaptoethanol and tributylphosphine; 
TBP). Identity of the protein was confirmed using two different specific antibodies; no bands were detected if the 
primary antibody was incubated with specific blocking peptide (SRD5A1 (A-18) peptide sc-20396 P) or in con-
trols lacking the primary antibodies. In all cases loading control was goat anti-actin (Santa-Cruz biotech sc-1616; 
predicted molecular weight 43 kDa). Membranes were incubated with species-specific fluorescent-conjugated 
secondary antibodies and visualised using the Licor Odyssey system (Licor). Protein bands detected by Western 
blot were quantified by performing densitometry analysis using ImageJ (NIH.gov). Data were normalised to 
Actin and expressed as fold-change relative to control treatment.
Immunofluorescence. Immunofluorescence was carried out on ESC grown on chamber slides (BD 
Biosciences) incubated with control media or DM to identify the localisation of the proteins within the cell and as 
numbers of primary cells were limited only one time point was selected (4 days). In line with expectations, both 
AKR1C3 and SRD5A1 were localised to the cytoplasm of the primary ESC a finding consistent with expression 
within the endoplasmic reticulum. Primary antibodies; rabbit anti-SRD5A1 (Santa-Cruz Biotech; sc-20658) and 
rabbit anti-AKR1C3 (Abcam, Ab137546) were incubated overnight at 4 °C. Antigen detection was performed 
using a Tyramide signal amplification (Perkin Elmer) system followed by SYTOXGreen nuclear counterstain 
(Life technologies). Images were captured using a LSM 710 Confocal microscope (Zeiss). Cell morphology was 
assessed by phase-contract imaging using Axiovert 200 inverted microscope (Zeiss) with 5× objective.
ELISA. Testosterone (T), dihydrotestosterone (DHT) and Insulin-like Growth Factor Binding Protein 1 
(IGFBP1) were measured in culture supernatants. Media were assayed in duplicate. Assay specificities are 
described in Supplemental Tables 2–4.
Statistical analysis. Statistical analysis was performed using Graphpad prism. Student’s t test or One-way 
ANOVA were used to determine significance between treatments in data that were normally distributed. 
Non-parametric testing was utilised where sample sizes were insufficient to confirm normality of data distribu-
tion; Mann-Whitney test or Kruskal-Wallis test was used to assess differences between treatments. Where data 
were analysed as fold change significance was tested using one sample t test and a theoretical mean of 1. Criterion 
for significance was p < 0.05. All data are presented as mean ± SEM.
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